International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 857-868 doi: 10.5281/zenodo.16914638
Original Article
Ocimum Sanctum Leaf Juice – An Antioxidant Nutraceutical for Prophylactic Therapy of Diabetes Mellitus, Infectious Pneumonia and Heat Stroke in People of Midnapur
Published
Aug. 20, 2025
Abstract

The present study evaluated the prophylactic and safety of Ocimum sanctum. Linn leaf juice in diabetes mellitus, infectious pneumonia and heat stroke among adult inhabitants of East and West Midnapur in West Bengal. Three hundred participants with age in the range of 45-60 years and comorbidity-free people were recruited and divided into three groups: the experimental (n=100), the safety (n=100), and the control (n=100). Experimental group was orally administered Tulsi leaf juice once daily and 28 days continuously at 5 g/kg body weight with an empty stomach during winter and summer seasons. The safety group individual was monitored on side-effects, weight variation, and changes in appetite. Telephonic and direct follow-up was done in terms of clinical outcomes in terms of the incidence of the disease being targeted, and related symptoms. Statistical testing of the analysis revealed that Tulsi leaf juice was tolerated with no side effects or changes in appetite and body weight. Significantly, none of the experimental subjects had diabetes, pneumonia, or heat stroke, whereas the control group had a cumulative disease incidence of 16%. Comparative seasonal surveys revealed consistent prophylactic efficacy, and clinical monitoring of complete absence of symptoms in the experimental group. These results indicate that daily intake of Ocimum sanctum. Linn leaf juice is safe, non-toxic, and effective as prophylactic therapy against metabolic, respiratory, and heat-associated health hazards in normal healthy adults

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
2673 Views
324 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved